(NASDAQ: JAGX) Jaguar Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 46.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.
Jaguar Health's earnings in 2025 is -$38,492,000.On average, 1 Wall Street analyst forecast JAGX's earnings for 2025 to be -$34,713,215, with the lowest JAGX earnings forecast at -$34,713,215, and the highest JAGX earnings forecast at -$34,713,215.
In 2026, JAGX is forecast to generate -$16,345,543 in earnings, with the lowest earnings forecast at -$16,345,543 and the highest earnings forecast at -$16,345,543.